Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

2009 Revenues for Drug Products in China Likely to Top $110 Billion

publication date: Aug 26, 2009

According to a new report from Wicon International, the total amount of revenue generated by drug products in China during 2009 is expected to grow by 80 billion RMB ($12 billion) to reach 563 billion RMB ($82 billion), an increase of at least 16% over the year earlier. Experts think a variety of factors may move the final number much higher, closer to a 20-25% increase. The official PRC government statistics for the first five months of 2009 show total pharmaceutical sales reached 322 billion RMB ($47.4 billion) for the period, implying full-year 2009 would equal 773 billion RMB ($113.7 billion) if the industry keeps up its pace. More details...



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital